Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience
J Infect Dis. 2022 Jan 18;225(2):352-354.
doi: 10.1093/infdis/jiab406.